Filing Details
- Accession Number:
- 0001209191-23-041189
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-05 17:05:12
- Reporting Period:
- 2023-06-30
- Accepted Time:
- 2023-07-05 17:05:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1810182 | Alx Oncology Holdings Inc | ALXO | Pharmaceutical Preparations (2834) | 850642577 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1857740 | Shelly Pinto | C/O Alx Oncology Holdings Inc. 323 Allerton Avenue South San Francisco CA 94080 | Vp, Finance And Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-06-30 | 466 | $7.34 | 63,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
- Includes 1,427 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023.